Tower Research Capital (TRC)’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,302
Closed -$21.9K – 6221
2026
Q2
$21.9K Buy
+2,302
New +$19.7K ﹤0.01% 3466
2026
Q1
– Sell
-1,231
Closed -$32.5K – 5640
2025
Q4
$32.5K Buy
1,231
+797
+184% +$15.4K ﹤0.01% 2749
2025
Q3
$8.28K Buy
434
+201
+86% +$3.13K ﹤0.01% 4053
2025
Q2
$4.53K Sell
233
-459
-66% -$8.9K ﹤0.01% 4312
2025
Q1
$9.9K Buy
692
+224
+48% +$4.29K ﹤0.01% 3710
2024
Q4
$11.6K Buy
468
+72
+18% +$2.01K ﹤0.01% 3699
2024
Q3
$12K Buy
396
+305
+335% +$11.9K ﹤0.01% 3628
2024
Q2
$4.66K Sell
91
-363
-80% -$28K ﹤0.01% 4752
2024
Q1
$40.3K Buy
+454
New +$45.9K ﹤0.01% 2422

Other funds holding GUTS

Tower Research Capital (TRC)'s GUTS Position: Q3 2026 in Review

Tower Research Capital (TRC) sold out of Fractyl Health (GUTS) in Q3 2026, closing a stake of 2,302 shares — an estimated $21.9K sold.

Tower Research Capital (TRC) first reported a position in GUTS in Q1 2024 and held it in 9 quarters. The position peaked at $40.3K in Q1 2024. 75 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.

  • Tower Research Capital (TRC) reported no remaining Fractyl Health position as of Q3 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,302 Fractyl Health shares in Q3 2026, an estimated $21.9K.
  • Tower Research Capital (TRC) first reported a position in Fractyl Health in Q1 2024 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Fractyl Health position peaked at $40.3K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.